Amy An

Amy An is an Emeritus Lecturer in the Department of Accounting at the Tippie College of Business, University of Iowa. Her research focuses on virology, antiviral drug development, and infectious disease mechanisms, particularly in influenza and coronaviruses. She has contributed to studies on viral entry inhibition, host immune response modulation, and antiviral compound design.

Her work spans molecular biology, immunology, and medicinal chemistry, with notable studies on organosilicon compounds as influenza entry inhibitors and the role of spike protein glycosylation in betacoronavirus pathogenesis. Recent research includes protocols for SARS-CoV-2 replicon systems and synergistic antiviral therapies.

Dr. An’s publications highlight interdisciplinary approaches to combat viral infections, emphasizing both therapeutic development and fundamental virology. Her findings have implications for pandemic preparedness and novel antiviral strategies.